$VICR

BlackRock (VICR holder) discloses 6.7% beneficial stake in Vicor in latest 13G/A

BlackRock (VICR holder) discloses 6.7% beneficial stake in Vicor in latest 13G/A Rhea-AI Filing Summary BlackRock, Inc. has filed an amended Schedule 13G reporting beneficial ownership of 2,265,870 shares of VICOR CORPORATION common stock, representing 6.7% of the outstanding class. BlackRock reports sole voting power over 2,202,331 shares and sole dispositive power over 2,265,870 shares, with no shared voting or dispositive power.

Original reporting
Published Jul 30, 2026, 3:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 6:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

This updates the ownership map and confirms sole voting and dispositive authority for the reported shares, which can matter for governance and takeover sensitivity, but the article contains no stated plans for corporate action.

02

Market read

Traders may monitor for follow-on filings (13D, additional amendments) if ownership intent changes, but this specific disclosure alone is unlikely to drive a major repricing.

03

What to watch

Schedule 13G/A does not necessarily imply activist intent; the article also states no single underlying client exceeds 5%, which can reduce the likelihood of concentrated control behavior.

Relevance 4/10Novelty 5/10Timing: filed/amended 13G/A reported on 2026-07-30

Background

Schedule 13G/A filings disclose beneficial ownership above reporting thresholds, typically for investment purposes rather than control.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

BlackRock amended its Schedule 13G/A to report 2,265,870 shares, or 6.7% of Vicor’s outstanding common stock, with sole voting and dispositive power.

Expected impact

Likely limited immediate price impact; any move would be sentiment-driven around ownership concentration rather than fundamentals.

Evidence & confidence

The filing is a regulatory ownership update (beneficial ownership and voting/dispositive power) without disclosed intent to control, transact, or change strategy. Such disclosures can matter for takeover dynamics, but the article provides no follow-on action or timeline.

Market effects

Minor read-through for the industrial/energy electronics supply chain only; no sector-wide signal is provided.

None indicated; this is a US SEC beneficial ownership filing for a single issuer.

Limited, as the disclosure is issuer-specific and does not reference cross-border transactions.

Counterpoint

The 6.7% figure may reflect client/mandate allocations within BlackRock rather than a strategic bet, so the market may overreact to the headline ownership percentage.

Key entities

  • VICOR CORPORATION

    The company whose common stock beneficial ownership is reported as 6.7% by BlackRock in the amended Schedule 13G/A.

  • BlackRock, Inc.

    Filed the amended Schedule 13G/A reporting beneficial ownership and sole voting/dispositive power over the disclosed VICR shares.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ:

$VICRMedAI 8/10

Vicor (NASDAQ:VICR) Reaches New 12

Vicor (NASDAQ:VICR) reached a new 52-week high on Wednesday, trading up to $334.62 and last at $332.95 versus a prior close of $267.99, with 1,586,277 shares traded. The stock also followed its April 21 quarterly results: EPS $0.44 vs $0.40 expected; revenue $112.97M vs $109.05M. Analysts cited mixed ratings and targets.

$AEHRHighAI 9/10

Here's Why Aehr Test Systems Popped Higher Today

Aehr Test Systems shares rose about 16% on the day, after Vicor unexpectedly raised its second-quarter revenue guidance, according to Vicor. Vicor cited higher product revenues and royalties from an additional licensee. Aehr, which sells wafer-level burn-in test equipment for power semiconductors and AI processors, reported a $41M hyperscaler order, lifting orders to over $92M in fiscal 2026 H2.